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Sexual Function Is an Indicator of Central Arterial Stiffness and
Arterial Stiffness Gradient in Japanese Adult Men
Hiroshi Kumagai, PhD; Toru Yoshikawa, PhD; Kanae Myoenzono, MS; Keisei Kosaki, PhD; Nobuhiko Akazawa, PhD; Zempo-Miyaki Asako,
PhD; Takehiko Tsujimoto, PhD; Tetsuhiro Kidokoro, PhD; Kiyoji Tanaka, PhD; Seiji Maeda, PhD
Background-—As arterial stiffness increases in the absence of subjective symptoms, a personal indicator that reﬂects increased
risk of cardiovascular disease is necessary. Penile erection is regulated by vascular function, and atherosclerosis affects the penile
artery earlier than it affects the coronary and carotid arteries. Therefore, we hypothesized that deterioration of erectile function
could be a marker of increased risk for cardiovascular disease. To test our hypothesis, we assessed erectile function and arterial
stiffness in a cross-sectional study.
Methods and Results-—Carotid-femoral pulse wave velocity (PWV), brachial-ankle PWV, femoral-ankle PWV, and arterial stiffness
gradient (PWV ratio: carotid-femoral PWV/femoral-ankle PWV) were measured as indexes of central, systemic, and peripheral
arterial stiffness and peripheral organ damage, respectively, in 317 adult men. In addition, erectile function was assessed by using
the questionnaire International Index of Erectile Function 5 (a descending score indicates worsening of erectile function). The
scores of male sexual function were inversely correlated with carotid-femoral PWV (rs=0.41), brachial-ankle PWV (rs=0.35),
femoral-ankle PWV (rs=0.19), and PWV ratio (rs=0.33). Furthermore, multivariate linear regression analyses revealed that
International Index of Erectile Function 5 scores were signiﬁcantly associated with carotid-femoral PWV (b=0.22) and PWV ratio
(b=0.25), but not with brachial-ankle PWV and femoral-ankle PWV.
Conclusions-—Our results indicated that erectile function is independently associated with central arterial stiffness and peripheral
organ damage. These ﬁndings suggest that male sexual function could be an easily identiﬁable and independent marker of
increased central arterial stiffness and peripheral organ damage. ( J Am Heart Assoc. 2018;7:e007964. DOI: 10.1161/JAHA.
117.007964.)
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C ardiovascular disease (CVD) is the leading cause ofdeath worldwide. In 2015, an estimated 17.7 million
individuals died from CVD, accounting for 31% of all global
deaths.1 It is now widely recognized that increased arterial
stiffness, especially central arterial stiffness, is associated
with future CVD events and all-cause mortality in a strong and
independent manner.2–7 Besides, it is well known that CVD is
a “silent killer,”8,9 and no subjective symptoms are present
when the systemic arteries stiffen. Thus, it is necessary to
establish easily identiﬁable markers that reﬂect increases in
arterial stiffness.
Erectile dysfunction (ED) is characterized by the inability to
attain or maintain penile erection that is sufﬁcient for
satisfactory sexual performance10; it is a common clinical
concern worldwide, with thousands of new patients diagnosed
every year.11,12 Penile erection is regulated by an increase in
arterial blood ﬂow and a decrease in venous blood ﬂow in the
penis. Previously, it was demonstrated that atherosclerosis
affects all major vascular beds to the same extent, and the
penile artery, which is smaller in diameter, is affected earlier
than the coronary and carotid arteries.13–15 Therefore, penile
erectile function could potentially be an early indicator of
increased risk for CVD. However, this possible association
remains poorly understood.
This study aimed to investigate the association between
penile erectile function and arterial stiffness in adult men. We
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hypothesized that erectile function is associated with arterial
stiffness and that deterioration of erectile function could
potentially be a marker of increased arterial stiffness. To test
our hypothesis, we assessed erectile function and arterial
stiffness in a cross-sectional study of adult men.
Methods
Participants
We recruited subjects through local newspaper advertise-
ments. A total of 317 adult men (age range, 23–88 years)
participated in this study. The diagnosis of hypertension was
based on a brachial systolic blood pressure ≥140 mm Hg
and/or treatment with antihypertensive agents, dyslipidemia
was based on a low-density lipoprotein cholesterol ≥140 mg/
dL and/or treatment with antihypercholesterolemic agents,
and diabetes mellitus was based on a fasting blood glucose
concentration ≥126 mg/dL and/or treatment with antihyper-
glycemic agents.16 Participants who ate, took medicines, or
smoked in the morning of the measurement day and those
who were undergoing treatment for ED were excluded from
this study. The study was approved by the ethics committee
of the Faculty of Health and Sport Sciences at the University
of Tsukuba (approval No. 27-68), and it conformed to the
principles outlined in the Declaration of Helsinki. All partic-
ipants were asked to provide written informed consent before
inclusion in the study. The data, analytic methods, and study
materials will not be made available to other researchers for
purposes of reproducing the results or replicating the
procedure.
Procedures
Measurements were obtained in a quiet temperature-con-
trolled room (24°C–26°C). First, blood samples were drawn to
evaluate the blood chemistry of the participants. Subse-
quently, blood pressure and arterial stiffness were measured
after a resting period of at least 20 minutes, after which
questionnaires on male sexual function were distributed to
the participants.
Anthropometric Measurements
A digital scale was used to measure the body weight of the
participants to the nearest 0.1 kg. A wall-mounted stadiome-
ter was used to measure their height to the nearest 0.1 cm.
Body mass index was calculated by dividing the weight (kg) of
the participants by their height (m2). Waist circumference was
directly measured on the skin at the level of the umbilicus,
with the participant in a standing position. Measurements
were made in duplicate to the nearest 0.1 cm.
Blood Biochemistry
Blood samples were collected from each participant after a
12-hour overnight fast, in the morning. Serum concentrations
of triglycerides, total cholesterol, high-density lipoprotein
cholesterol, and low-density lipoprotein cholesterol and
plasma concentrations of glucose and glycosylated hemoglo-
bin were determined using standard enzymatic techniques.
Serum total testosterone levels were measured using chemi-
luminescent immunoassay by a commercial laboratory (LSI
Medience Corp, Ibaraki, Japan).
Heart Rate, Blood Pressure, Arterial Stiffness, and
Arterial Stiffness Gradient
After a resting period of at least 20 minutes, heart rate, blood
pressure, and arterial stiffness were measured in a quiet
temperature-controlled room (24°C–26°C). Heart rate, sys-
tolic blood pressure, diastolic blood pressure, mean arterial
pressure, carotid-femoral pulse wave velocity (cfPWV),
brachial-ankle PWV (baPWV), and femoral-ankle PWV (faPWV)
were measured using a previously described noninvasive
vascular proﬁling system (form PWV/ABI; Colin Medical
Technology, Komaki, Japan).17,18 Of the direct carotid-femoral
distance, 80% was applied to calculate cfPWV.19 Carotid and
femoral artery pulse waves were simultaneously obtained
using 2 applanation tonometers incorporating an array of 15
Clinical Perspective
What Is New?
• This study investigated whether deterioration of sexual
function could be a marker of increased arterial stiffness in
men.
• Deterioration of erectile function was associated with
elevated central arterial stiffness and index of peripheral
organ damage after adjusting by age, blood pressure, and
other confounders, but not with peripheral arterial stiffness.
What Are the Clinical Implications?
• Our ﬁndings suggest that the deterioration of erectile
function, as assessed by questionnaires, has the potential
for being an easily identiﬁable and independent marker of
increased central arterial stiffness and peripheral organ in
men, such as in the brain and kidney.
• Because cardiovascular disease is a leading cause of death
and is a “silent killer,” our ﬁndings have a large clinical
signiﬁcance as a personal and independent indicator.
• Earlier detection of elevated central arterial stiffness by
erectile function might contribute to preventive or treatment
activity for cardiovascular disease.
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micropiezoresistive transducers. Bilateral brachial and poste-
rior tibial arterial pressure waveforms were recorded using
extremity cuffs connected to air plethysmographic sensors
wrapped on both arms and ankles of the participants. The
distances traveled by the pulse waves were assessed in
triplicate with a random zero-length measurement over the
surface of the body using a nonelastic tape measure. Pulse
wave transit time was determined from the time delay
between the proximal and distal “foot” waveforms. The foot of
the wave was automatically identiﬁed and detected as the
commencement of a sharp systolic upstroke. PWV was
assessed in duplicate and was calculated as the distance
divided by the transit time. In addition, arterial stiffness
gradients (PWV ratio: central arterial stiffness/peripheral
arterial stiffness) were calculated by dividing cfPWV by faPWV.
Recently, it was reported that the PWV ratio is a better
predictor of mortality than the classic cfPWV is,20 and it
reﬂects peripheral organ damage.21,22
Male Sexual Function
Male erectile function was assessed by using 2 question-
naires, the International Index of Erectile Function (IIEF) 5 and
the Aging Males’ Symptoms (AMS), because questionnaires
are not objective methods.
The IIEF questionnaire, which was developed and validated
in 1997, was adopted as the gold standard for the assess-
ment of ED.23,24 The IIEF5 is the short form of the IIEF, and its
scores range from 5 to 25 points, in which descending scores
indicate worsening of erectile function. According to previous
studies, individuals with 5 to 7 points on the IIEF5 were
diagnosed as having severe ED; those with 8 to 11 points, as
having moderate ED; those with 12 to 16 points, as having
mild to moderate ED; those with 17 to 21 points, as having
mild ED; and those with 22 to 25 points, as having no ED.25,26
The AMS questionnaire contains 17 self-rating symptom-
based questions, according to 3 subscales; 7 of the questions
are somatic, 5 are psychological, and 5 are sexual.27 The total
sum of all subscales provides a total score, and the sum of the
scores of somatic, psychological, and sexual types of
questions is also calculated. Contrary to the IIEF5 scores,
the ascending scores indicate worsening of each function in
the AMS.
Statistical Analysis
The Shapiro-Wilk test was used to assess the normality of all
parameters. Data were expressed as the meansSD or
frequency counts (for categorical data). Moreover, values
were analyzed using Spearman’s rank correlation coefﬁcients
(rs) and Kruskal-Wallis nonparametric tests with post hoc
paired comparisons, as appropriate. The variables of skewed
distributions were log transformed to obtain normal distribu-
tions before multivariate linear regression analyses. Indepen-
dent correlates of log-transformed cfPWV, faPWV, and PWV
ratio were examined using multivariate linear regression
analyses. The frequencies of principal risk factors, medica-
tions, and medical histories were analyzed using v2 tests.
Statistical signiﬁcance was set at P<0.05 for all comparisons.
Statistical analyses were performed using JMP Pro version 12
(SAS Institute).
Results
The number of participants who took antihypertensive,
antihypercholesterolemic, and antihyperglycemic agents was
80 (25.2%), 41 (12.9%), and 16 (5.0%), respectively. Moreover,
9 participants (2.8%) had a history of angina, 3 (0.9%) had a
history of myocardial infarction, and 7 (2.2%) had a history of
stroke. Twenty-one participants (6.6%) were current smokers.
The mean values of body mass index (23.8 kg/m2), total
cholesterol (207 mg/dL), high-density lipoprotein cholesterol
(61 mg/dL), low-density lipoprotein cholesterol (122 mg/dL),
triglycerides (115 mg/dL), glucose (103 mg/dL), glycosy-
lated hemoglobin (5.5 mg/dL), testosterone (20.6 nmol/L),
systolic blood pressure (127 mm Hg), and diastolic blood
pressure (79 mm Hg) were within the normal ranges
(Table 1).
The average IIEF5 score (descending scores indicate
worsening of erectile function) was lowered, whereas the
AMS sexual score (ascending scores indicates worsening of
erectile function) was elevated, for each age group, which
indicated that erectile function decreases with advancing age
(Figure 1). In addition, age was signiﬁcantly correlated with
cfPWV (rs=0.61, P<0.001), baPWV (rs=0.69, P<0.001), faPWV
(rs=0.34, P<0.001), and PWV ratio (rs=0.45, P<0.001). cfPWV
was signiﬁcantly correlated with baPWV (rs=0.75, P<0.001),
faPWV (rs=0.38, P<0.001), and PWV ratio (rs=0.85, P<0.001);
baPWV was signiﬁcantly correlated with faPWV (rs=0.71,
P<0.001) and PWV ratio (rs=0.40, P<0.001); and faPWV was
signiﬁcantly correlated with PWV ratio (rs=0.12, P=0.032).
The IIEF5 scores were negatively correlated with cfPWV
(rs=0.41, P<0.001), baPWV (rs=0.35, P<0.001), faPWV
(rs=0.19, P<0.001), and PWV ratio (rs=0.33, P<0.001) in
all participants, and with cfPWV (rs=0.28, P<0.001), baPWV
(rs=0.17, P=0.027), and PWV ratio (rs=0.24, P=0.001) in
older participants (Figure 2). Similarly, the scores of the AMS
sexual subscale were positively correlated with cfPWV
(rs=0.39, P<0.001), baPWV (rs=0.39, P<0.001), faPWV
(rs=0.26, P<0.001), and PWV ratio (rs=0.28, P<0.001) in all
participants; with cfPWV (rs=0.35, P=0.036) and baPWV
(rs=0.37, P=0.024) in young participants; and with
cfPWV (rs=0.23, P=0.004), baPWV (rs=0.20, P=0.014), and
PWV ratio (rs=0.16, P=0.040) in older participants (Figure 3).
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To investigate the further associations between arterial
stiffness and each of the IIEF5 scores and AMS sexual scores,
we separately applied multivariate linear regression analyses.
We observed that the log-transformed IIEF5 scores were
signiﬁcantly associated with cfPWV (b=0.22, P<0.001) and
PWV ratio (b=0.25, P<0.001), but not with baPWV
(b=0.05, P=0.230) and faPWV (b=0.03, P=0.590) (Table 2).
Similarly, the log-transformed AMS sexual scores were
signiﬁcantly associated with cfPWV (b=0.11, P=0.043).
Table 3 and Figure 4 show the characteristics of partici-
pants classiﬁed by the severity of ED by IIEF5 score. The value
Table 1. Characteristics of Studied Men (n=317)
Characteristics Value
Age, y 5915
Height, cm 168.06.7
Body mass, kg 67.411.7
Body mass index, kg/m2 23.83.4
Waist circumference, cm 85.310.3
Total cholesterol, mg/dL 20736
HDL cholesterol, mg/dL 6115
LDL cholesterol, mg/dL 12233
Triglycerides, mg/dL 11566
Glucose, mg/dL 10319
HbA1c, mg/dL 5.50.5
Testosterone, nmol/L* 20.66.9
Hemodynamics
Systolic blood pressure, mm Hg 12715
Diastolic blood pressure, mm Hg 7911
Mean arterial pressure, mm Hg 9913
Pulse pressure, mm Hg 489
Heart rate, bpm 6110
cfPWV, cm/s 909206
baPWV, cm/s 1466274
faPWV, cm/s 957108
PWV ratio 0.950.21
Male functions
IIEF5 score, points 176
AMS total, points† 298
AMS somatic, points† 124
AMS psychological,
points†
72
AMS sexual, points† 114
Principal risk factors, n (%)
Hypertension 116 (36.6)
Dyslipidemia 115 (36.3)
Diabetes mellitus 31 (9.8)
Medications, n (%)
Antihypertensive 80 (25.2)
Antihypercholesterolemic 41 (12.9)
Antihyperglycemic 16 (5.0)
Medical history, n (%)
Angina 9 (2.8)
Myocardial infarction 3 (0.9)
Stroke 7 (2.2)
Current smoking, n (%) 21 (6.6)
Data are shown as the meanSD or frequency count (percentage), as appropriate. AMS
indicates Aging Males’ Symptoms; baPWV, brachial-ankle PWV; bpm, beats per minute;
cfPWV, carotid-femoral PWV; faPWV, femoral-ankle PWV; HbA1c, glycosylated
hemoglobin; HDL, high-density lipoprotein; IIEF5, International Index of Erectile Function
5; LDL, low-density lipoprotein; and PWV, pulse wave velocity.
*Data are available in 304 individuals.
†Data are available in 253 individuals.
Figure 1. Age-related differences in the International Index of
Erectile Function 5 (IIEF5) scores (A) and the Aging Males’
Symptoms (AMS) sexual scores (B). Data available in 253
individuals in AMS sexual score. Data are expressed as
meanSD. aP<0.05 vs young-aged group, bP<0.05 vs middle-
aged group.
Table 1. Continued
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Figure 2. Correlations between the International Index of Erectile Function 5 (IIEF5) scores and carotid-femoral pulse wave
velocity (cfPWV), brachial-ankle PWV (baPWV), femoral-ankle PWV (faPWV), and PWV ratio in each age group (young-aged,
n=40; middle-aged, n=97; older-aged, n=180).
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Figure 3. Correlations between the Aging Males’ Symptoms (AMS) sexual scores and carotid-femoral pulse wave velocity
(cfPWV), brachial-ankle PWV (baPWV), femoral-ankle PWV (faPWV), and PWV ratio in each age group (young-aged, n=37;
middle-aged, n=57; older-aged, n=159).
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of cfPWV was signiﬁcantly higher in participants with mild ED,
mild to moderate ED, moderate ED, and severe ED than in
participants with no ED. In addition, cfPWV was signiﬁcantly
higher in participants with severe ED than in those with mild
ED and mild to moderate ED (Figure 4A). Besides, the value of
PWV ratio was signiﬁcantly higher in participants with mild to
moderate ED, moderate ED, and severe ED than in partic-
ipants with no ED. In addition, PWV ratio was signiﬁcantly
higher in participants with severe ED than in those with mild
ED and mild to moderate ED (Figure 4B).
Discussion
In the present study, we investigated the association between
penile erectile function and arterial stiffness in adult men. We
found signiﬁcant negative correlations between IIEF5 scores
and cfPWV, baPWV, faPWV, and PWV ratio. Multivariate linear
regression analyses demonstrated that IIEF5 scores were
signiﬁcantly associated with cfPWV and PWV ratio, but not
with baPWV and faPWV. Similar trends were found for AMS
sexual scores. These results suggest that the deterioration of
erectile function, as assessed by questionnaires, has the
potential for being an easily identiﬁable and independent
marker of increased central arterial stiffness and peripheral
organ damage in men. Earlier detection of elevated central
arterial stiffness by erectile function might contribute to the
preventive or treatment activity for CVD.
The association between male erectile function and
CVD has been demonstrated in many epidemiological
studies,25,28–31 and a previous meta-analysis has revealed
that, compared with reference groups, men with ED exhibited
signiﬁcantly increased risk of CVD (48%), coronary heart
disease (46%), and stroke (35%).32 These associations could
be attributed to endothelial dysfunction33 and the artery size
hypothesis.13–15 According to the artery size hypothesis,
atherosclerosis affects all major vascular beds to the same
extent, and penile arteries, which are smaller in diameter than
coronary and carotid arteries, are affected earlier by
atherosclerotic plaques of the same size. Systemic endothe-
lial dysfunction may cause the inability to regulate blood ﬂow
Table 2. Independent Correlates of cfPWV, baPWV, faPWV, and PWV Ratio
Variable
cfPWV
(R2=0.53, P<0.001)*
baPWV
(R2=0.61, P<0.001)*
faPWV
(R2=0.39, P<0.001)*
PWV Ratio
(R2=0.31, P<0.001)*
b P Value b P Value b P Value b P Value
Age, y* 0.411 <0.001 0.396 <0.001 0.246 <0.001 0.305 <0.001
Height, cm 0.173 <0.001 0.097 0.027 0.019 0.727 0.174 0.003
Waist circumference, cm* 0.127 0.013 0.061 0.190 0.024 0.681 0.157 0.012
Systolic blood pressure, mm Hg* 0.213 <0.001 0.373 <0.001 0.431 <0.001 0.003 0.965
HDL cholesterol, mg/dL* 0.006 0.912 0.013 0.778 0.001 0.990 0.010 0.871
LDL cholesterol, mg/dL* 0.020 0.660 0.045 0.285 0.001 0.976 0.017 0.754
Triglycerides, mg/dL* 0.023 0.662 0.007 0.891 0.055 0.362 0.004 0.951
Glucose, mg/dL* 0.183 <0.001 0.086 0.055 0.011 0.843 0.187 0.002
Testosterone, nmol/L* 0.072 0.107 0.051 0.208 0.020 0.701 0.086 0.113
Medications
Antihypertensive, yes/no 0.158 0.001 0.165 <0.001 0.120 0.031 0.108 0.064
Antihypercholesterolemic, yes/no 0.022 0.622 0.060 0.147 0.021 0.685 0.015 0.792
Antihyperglycemic, yes/no 0.001 0.988 0.016 0.718 0.020 0.722 0.008 0.898
Medical history
Angina, yes/no 0.031 0.478 0.014 0.724 0.003 0.946 0.039 0.458
Myocardial infarction, yes/no 0.027 0.524 0.043 0.264 0.101 0.039 0.025 0.623
Stroke, yes/no 0.039 0.362 0.051 0.192 0.050 0.313 0.064 0.224
Current smoking, yes/no 0.051 0.226 0.054 0.157 0.035 0.461 0.037 0.467
IIEF5 score, points* 0.226 <0.001 0.053 0.230 0.030 0.590 0.254 <0.001
Covariates included in the multiple linear regression models were age, height, waist circumference, systolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein
cholesterol, triglycerides, fasting blood glucose, testosterone, antihypertensive medication, antihypercholesterolemic medication, antihyperglycemic medication, medical history of angina,
myocardial infarction, and stroke, current smoking, and IIEF5 scores. baPWV indicates brachial-ankle PWV; cfPWV, carotid-femoral PWV; faPWV, femoral-ankle PWV; HDL, high-density
lipoprotein; IIEF5, International Index of Erectile Function 5; LDL, low-density lipoprotein; and PWV, pulse wave velocity.
*Log-transformed.
DOI: 10.1161/JAHA.117.007964 Journal of the American Heart Association 7
Male Sexual Function and Arterial Stiffness Kumagai et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on July 26, 2018
in the corpora cavernosa of the penis. However, the
mechanisms underlying the association between male erectile
function and CVD are not fully understood. In the present
study, we demonstrated that male erectile functions were
signiﬁcantly associated with arterial stiffness. Moreover, after
adjusting by covariance for differences in age and other
factors, male erectile functions were signiﬁcantly associated
with cfPWV, but not with baPWV and faPWV. Thus, our results
provide possible new explanations for the association
between erectile function and CVD. To the best of our
Table 3. Characteristics of Subjects Classiﬁed by the Severity of ED
Characteristics
No ED (IIEF5
Score >21)
Mild ED (IIEF5
Score 17–21)
Mild to Moderate
ED (IIEF5 Score 12–16)
Moderate ED
(IIEF5 Score 8–11)
Severe ED
(IIEF5 Score <8) P Value
Number 85 108 71 21 32 . . .
Age, y 4916 5713 6412 677 729 <0.001
Height, cm 169.76.3 169.36.3 165.46.9 167.55.9 164.76.6 <0.001
Body mass, kg 68.211.6 69.312.1 65.311.1 65.911.6 63.811 0.080
Body mass index, kg/m2 23.73.6 24.13.6 23.83.2 23.43.4 23.43.0 0.807
Waist circumference, cm 84.110.5 86.511.4 84.78.7 86.610.4 84.78.6 0.325
Total cholesterol, mg/dL 20334 20936 20836 21636 20745 0.769
HDL cholesterol, mg/dL 6116 6215 6015 6518 6016 0.856
LDL cholesterol, mg/dL 11931 12333 12336 12525 12135 0.915
Triglycerides, mg/dL 10859 11567 11978 12767 11854 0.533
Glucose, mg/dL 9918 10415 10317 11038 10719 0.010
HbA1c, mg/dL 5.40.6 5.50.6 5.60.5 5.70.6 5.60.5 0.017
Testosterone, nmol/L* 21.37.2 20.15.2 20.66.0 22.09.6 19.310.0 0.479
Hemodynamics
Systolic blood pressure, mm Hg 12415 12814 12614 12917 13516 0.001
Diastolic blood pressure, mm Hg 7712 8110 799 7811 8110 0.129
Mean arterial pressure, mm Hg 9513 10012 9911 9913 10513 0.001
Pulse pressure, mm Hg 478 478 479 5110 5412 0.007
Heart rate, bpm 6111 6211 6010 608 6310 0.731
baPWV, cm/s 1359230 1438251 1515277 1529275 1695295 <0.001
faPWV, cm/s 934111 956109 96597 95884 999123 0.059
Principal risk factors, n (%) 0.556
Hypertension 18 (21.1) 42 (38.9) 26 (36.6) 7 (33.3) 23 (71.9) <0.001
Dyslipidemia 24 (28.2) 40 (37.0) 28 (39.4) 9 (42.9) 14 (43.8) 0.423
Diabetes mellitus 6 (7.1) 10 (9.3) 6 (8.5) 2 (9.5) 7 (21.9) 0.185
Medications, n (%)
Antihypertensive 11 (12.9) 28 (25.9) 20 (28.2) 5 (23.8) 16 (50.0) 0.002
Antihypercholesterolemic 4 (4.7) 18 (16.7) 9 (12.7) 5 (23.8) 5 (15.6) 0.065
Antihyperglycemic 2 (2.4) 5 (4.6) 2 (2.8) 1 (4.8) 6 (18.8) 0.006
Medical history, n (%)
Angina 3 (3.5) 2 (1.9) 3 (4.2) 0 (0) 1 (3.1) 0.801
Myocardial infarction 1 (1.2) 0 (0) 0 (0) 0 (0) 2 (6.3) 0.021
Stroke 0 (0) 2 (1.9) 3 (4.2) 1 (4.8) 1 (3.1) 0.395
Current smoking, n (%) 6 (7.1) 4 (3.7) 7 (9.9) 2 (9.5) 2 (6.3) 0.556
Data are shown as the meanSD or frequency count (percentage), as appropriate. baPWV indicates brachial-ankle pulse wave velocity; bpm, beats per minute; ED, erectile dysfunction;
faPWV, femoral-ankle pulse wave velocity; HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; IIEF5, International Index of Erectile Function 5; and LDL, low-density lipoprotein.
*Data are available in 304 individuals.
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knowledge, this was the ﬁrst study to suggest that decreased
erectile function is an independent indicator of increased
central arterial stiffness in men.
In the present study, we demonstrated that erectile
function was signiﬁcantly associated with central arterial
stiffness. Similarly, Vlachopoulos et al have reported that
central arterial stiffness was higher in patients with hyper-
tension who had ED than in those without ED.34 These results
suggest that men with ED exhibit higher central arterial
stiffness than that exhibited by men without ED. On the
contrary, only in patients with ED, Vlachopoulos et al
investigated whether central arterial stiffness predicts major
adverse cardiovascular events.35 In their study, they con-
cluded that higher central arterial stiffness is associated with
increased risk for a major adverse cardiovascular event in
patients with ED,35 which suggested that the risk for major
adverse cardiovascular events varied even in these patients.
In the present study, we stratiﬁed the participants into 5
groups according to the severity of ED. As a result, the no ED
group had the lowest values of cfPWV (822170 cm/s), and
cfPWV was signiﬁcantly higher in participants with mild ED
(879160 cm/s), mild to moderate ED (927191 cm/s),
and moderate ED (982222 cm/s) than in participants
without ED. The differences in the values were 57, 105, and
160 cm/s, respectively. Moreover, participants with severe
ED had the highest values of cfPWV (1147252 cm/s), and
the difference in the values between participants with severe
ED and no ED was 325 cm/s. In a meta-analysis involving 15
longitudinal studies, Vlachopoulos et al indicated that an
increase in aortic PWV by 100 cm/s was signiﬁcantly
associated with an increased risk of 14% and 15% in total
CVD events and CVD mortality, respectively.36 These results
suggest that detailed classiﬁcation is effective for creating an
awareness about the increased risk for CVD.
Recently, it was reported that the arterial stiffness gradient,
which is the ratio of central arterial stiffness/peripheral arterial
stiffness, is a better predictor of mortality than the classic
cfPWV is.20 In addition, the loss or reversal of stiffness gradient
leads to transmission of a highly pulsatile pressure wave into
the microcirculation, causing peripheral organ damage.21,22 In
the present study, we found that the severity of ED was
signiﬁcantly associated with PWV ratio. These results support
our speculation that male sexual function has the potential for
being a personal indicator of increased CVD risk in men. In
addition, sexual function may reﬂect peripheral organ damage
in men, such as in the brain and kidney.
Testosterone is a male sex hormone and is associated with
both cardiovascular function and erectile function.37–39
Indeed, we have previously reported that lifestyle modiﬁcation
induced-increased circulating testosterone levels were signif-
icantly associated with improved cardiovascular functions in
overweight and obese men.40,41 However, in the present
study, no signiﬁcant association was observed between
serum testosterone levels and both arterial stiffness and
severity of ED. These inconsistent results may be caused by
the differences in circulating testosterone levels. Akishita
et al have demonstrated that men with circulating total
testosterone levels <14.2 nmol/L had an 4-fold higher CVD
risk than men with higher circulating testosterone levels,38
and Vlachopoulos et al have reported that circulating testos-
terone level was signiﬁcantly associated with arterial stiffness
in normal men and in those with testosterone deﬁciency (the
average testosterone levels were 14.9 nmol/L).37 In addition,
in our previous studies, the average levels of circulating
testosterone at baseline were 11.1 and 12.3 nmol/L in
overweight and obese men, respectively.40,41 In the present
study, the average levels of serum testosterone were
20.6 nmol/L, and circulating testosterone levels of the
participants were higher than those reported in other previous
studies. These results implied that low circulating
Figure 4. Association between severity of erectile dysfunction
(ED) classiﬁed by International Index of Erectile Function 5 score
and carotid-femoral pulse wave velocity (cfPWV; A) and PWV ratio
(B). Data are expressed as meanSD. aP<0.05 vs no erectile
dysfunction, bP<0.05 vs mild ED, cP<0.05 vs mild to moderate ED.
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testosterone levels might be associated with impaired
cardiovascular and sexual functions in men.
A previous study has reported that ED is an independent
predictor of peripheral artery disease, as determined by ankle-
brachial index.42 However, in the present study, ED was not
associated with faPWV as an index of peripheral arterial
stiffness. This discrepancy could be explained by the locations
of the arteries. In human circulation, blood ﬂows from the heart
to the penile artery through the central and not the peripheral
artery. Thus, penile erectile function was not inﬂuenced by
peripheral arteries. Another explanation could be the charac-
teristics of peripheral artery. Central arterial stiffness signiﬁ-
cantly increases with aging, whereas peripheral arterial stiffness
remains unchanged21 or slightly decreases with aging.43 Thus,
faPWV, as an index of peripheral arterial stiffness, may
underestimate the aging-induced structural changes in arteries.
The present study has several limitations. First, we did not
measure the inﬂammation levels, although the markers, such
as C-reactive protein and interleukin-6, were associated with
vascular functions, including erectile function.34,44,45 Second,
we did not measure peripheral organ function, such as that of
the brain and kidney, and assessed only the PWV ratio as an
index of peripheral organ damage. This issue will be
addressed in our future study. Finally, we could not reveal
the cause of ED and the causal relationship between arterial
stiffness and male sexual function because of the cross-
sectional study. A future longitudinal study will be necessary
to reveal the causal relationship.
In the present study, we investigated the association
between penile erectile function and arterial stiffness in adult
men. There were signiﬁcant negative correlations between
IIEF5 score and cfPWV, baPWV, faPWV, and PWV ratio.
Moreover, multivariate linear regression analyses demon-
strated that IIEF5 scores were signiﬁcantly associated with
only cfPWV and PWV ratio, but not with baPWV and faPWV.
Similar trends were found for AMS sexual scores. Therefore,
our results suggest that deterioration of erectile function, as
assessed using questionnaires, has the potential for being a
personal and independent indicator of increased central
arterial stiffness.
Acknowledgments
We thank the research members of S.M.’s laboratory in University of
Tsukuba for technical assistance; and Dr Noriyuki Fuku in Juntendo
University for statistical assistance.
Sources of Funding
This work was supported by a grant-in-aid for Scientiﬁc
Research KAKENHI from the Ministry of Education, Culture,
Sports, Science, and Technology, Japan (15K12692 to
Maeda). Kumagai and Kosaki were recipients of a Grant-in-
Aid for JSPS Fellow from the Japan Society for Promotion of
Science (17J10817 and 17J01405, respectively).
Disclosures
None.
References
1. World Health Organization. Cardiovascular disease. Fact sheet on CVDs. 2017.
2. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent
S. Aortic stiffness is an independent predictor of primary coronary events in
hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15.
3. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P,
Benetos A. Aortic stiffness is an independent predictor of all-cause and
cardiovascular mortality in hypertensive patients. Hypertension.
2001;37:1236–1241.
4. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave
velocity predicts cardiovascular mortality in subjects >70 years of age.
Arterioscler Thromb Vasc Biol. 2001;21:2046–2050.
5. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita
JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the
Framingham Heart Study. Circulation. 2010;121:505–511.
6. Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C.
Prediction of cardiovascular events and all-cause mortality with central
haemodynamics: a systematic review and meta-analysis. Eur Heart J.
2010;31:1865–1871.
7. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen
H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of
arterial stiffness in the general population. Circulation. 2006;113:664–670.
8. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata
DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM,
Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT,
Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB,
McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP,
Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner
MB; American Heart Association Statistics Committee and Stroke Statistics
Subcommittee. Heart disease and stroke statistics—2013 update: a report
from the American Heart Association. Circulation. 2013;127:e6–e245.
9. World Health Organization. A global brief on hypertension. 2013. http://www.
who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/
10. NIH Consensus Development Panel on Impotence. NIH Consensus Confer-
ence: impotence. JAMA. 1993;270:83–90.
11. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile
dysfunction between 1995 and 2025 and some possible policy consequences.
BJU Int. 1999;84:50–56.
12. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence
and its medical and psychosocial correlates: results of the Massachusetts
Male Aging Study. J Urol. 1994;151:54–61.
13. Gandaglia G, Briganti A, Jackson G, Kloner RA, Montorsi F, Montorsi P,
Vlachopoulos C. A systematic review of the association between erectile
dysfunction and cardiovascular disease. Eur Urol. 2014;65:968–978.
14. Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the “tip of the
iceberg” of a systemic vascular disorder? Eur Urol. 2003;44:352–354.
15. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A, Rigatti
P, Montorsi F. The artery size hypothesis: a macrovascular link between
erectile dysfunction and coronary artery disease. Am J Cardiol. 2005;96:
19M–23M.
16. Hashimoto J, Ito S. Aortic blood ﬂow reversal determines renal function:
potential explanation for renal dysfunction caused by aortic stiffening in
hypertension. Hypertension. 2015;66:61–67.
17. Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA,
Tanaka H. Brachial-ankle pulse wave velocity: an index of central arterial
stiffness? J Hum Hypertens. 2005;19:401–406.
18. Sugawara J, Hayashi K, Yokoi T, Tanaka H. Age-associated elongation of the
ascending aorta in adults. JACC Cardiovasc Imaging. 2008;1:739–748.
19. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De
Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD,
Schillaci G, Segers P, Vermeersch S, Weber T; Artery Society; European
DOI: 10.1161/JAHA.117.007964 Journal of the American Heart Association 10
Male Sexual Function and Arterial Stiffness Kumagai et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on July 26, 2018
Society of Hypertension Working Group on Vascular Structure and Function;
European Network for Noninvasive Investigation of Large Arteries. Expert
consensus document on the measurement of aortic stiffness in daily practice
using carotid-femoral pulse wave velocity. J Hypertens. 2012;30:445–448.
20. Fortier C, Mac-Way F, Desmeules S, Marquis K, De Serres SA, Lebel M,
Boutouyrie P, Agharazii M. Aortic-brachial stiffness mismatch and mortality in
dialysis population. Hypertension. 2015;65:378–384.
21. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS,
Levy D. Changes in arterial stiffness and wave reﬂection with advancing age in
healthy men and women: the Framingham Heart Study. Hypertension.
2004;43:1239–1245.
22. Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse
pressure in CKD and ESRD. Kidney Int. 2012;82:388–400.
23. Rosen RC, Cappelleri JC, Gendrano N III. The International Index of Erectile
Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226–244.
24. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The
International Index of Erectile Function (IIEF): a multidimensional scale for
assessment of erectile dysfunction. Urology. 1997;49:822–830.
25. Bohm M, Baumhakel M, Teo K, Sleight P, Probstﬁeld J, Gao P, Mann JF, Diaz R,
Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S; ONTARGET/TRANSCEND
Erectile Dysfunction Substudy Investigators. Erectile dysfunction predicts
cardiovascular events in high-risk patients receiving telmisartan, ramipril, or
both: the ONgoing Telmisartan Alone and in combination with Ramipril Global
Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant
subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circu-
lation. 2010;121:1439–1446.
26. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and
evaluation of an abridged, 5-item version of the International Index of Erectile
Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res.
1999;11:319–326.
27. Heinemann LA, Saad F, Zimmermann T, Novak A, Myon E, Badia X, Potthoff P,
T’Sjoen G, Pollanen P, Goncharow NP, Kim S, Giroudet C. The Aging Males’
Symptoms (AMS) scale: update and compilation of international versions.
Health Qual Life Outcomes. 2003;1:15.
28. Araujo AB, Hall SA, Ganz P, Chiu GR, Rosen RC, Kupelian V, Travison TG,
McKinlay JB. Does erectile dysfunction contribute to cardiovascular disease
risk prediction beyond the Framingham risk score? J Am Coll Cardiol.
2010;55:350–356.
29. Chew KK, Finn J, Stuckey B, Gibson N, Sanﬁlippo F, Bremner A, Thompson P,
Hobbs M, Jamrozik K. Erectile dysfunction as a predictor for subsequent
atherosclerotic cardiovascular events: ﬁndings from a linked-data study. J Sex
Med. 2010;7:192–202.
30. Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, Valenti
C, Giustina A, Garzaniti A. Erectile dysfunction as a predictor of
cardiovascular events and death in diabetic patients with angiographically
proven asymptomatic coronary artery disease: a potential protective role for
statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol.
2008;51:2040–2044.
31. Thompson IM, Tangen CM, Goodman PJ, Probstﬁeld JL, Moinpour CM, Coltman
CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA.
2005;294:2996–3002.
32. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular
disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol.
2011;58:1378–1385.
33. Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Stefanadis C. The triad:
erectile dysfunction—endothelial dysfunction—cardiovascular disease. Curr
Pharm Des. 2008;14:3700–3714.
34. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Tsekoura D,
Vasiliadou C, Stefanadi E, Askitis A, Stefanadis C. Arterial function and
intima-media thickness in hypertensive patients with erectile dysfunction. J
Hypertens. 2008;26:1829–1836.
35. Vlachopoulos C, Ioakeimidis N, Aznaouridis K, Terentes-Printzios D, Rokkas K,
Aggelis A, Panagiotakos D, Stefanadis C. Prediction of cardiovascular events
with aortic stiffness in patients with erectile dysfunction. Hypertension.
2014;64:672–678.
36. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular
events and all-cause mortality with arterial stiffness: a systematic review and
meta-analysis. J Am Coll Cardiol. 2010;55:1318–1327.
37. Vlachopoulos C, Ioakeimidis N, Miner M, Aggelis A, Pietri P, Terentes-Printzios
D, Tsekoura D, Stefanadis C. Testosterone deﬁciency: a determinant of aortic
stiffness in men. Atherosclerosis. 2014;233:278–283.
38. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M, Ouchi Y. Low
testosterone level as a predictor of cardiovascular events in Japanese men
with coronary risk factors. Atherosclerosis. 2010;210:232–236.
39. Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C,
Piepoli M, Fini M, Rosano GM. Effect of long-acting testosterone treatment on
functional exercise capacity, skeletal muscle performance, insulin resistance,
and baroreﬂex sensitivity in elderly patients with chronic heart failure a
double-blind, placebo-controlled, randomized study. J Am Coll Cardiol.
2009;54:919–927.
40. Kumagai H, Zempo-Miyaki A, Yoshikawa T, Tsujimoto T, Tanaka K, Maeda S.
Lifestyle modiﬁcation increases serum testosterone level and decrease central
blood pressure in overweight and obese men. Endocr J. 2015;62:423–430.
41. Kumagai H, Miyaki A, Higashino R, Akazawa N, Choi Y, Ra S, Eto M, Tanaka K,
Ajisaka R, Maeda S. Lifestyle modiﬁcation-induced increase in serum
testosterone and SHBG decreases arterial stiffness in overweight and obese
men. Artery Res. 2014;8:80–87.
42. Polonsky TS, Taillon LA, Sheth H, Min JK, Archer SL, Ward RP. The association
between erectile dysfunction and peripheral arterial disease as determined by
screening ankle-brachial index testing. Atherosclerosis. 2009;207:440–444.
43. Zhang Y, Agnoletti D, Protogerou AD, Topouchian J, Wang JG, Xu Y, Blacher J,
Safar ME. Characteristics of pulse wave velocity in elastic and muscular
arteries: a mismatch beyond age. J Hypertens. 2013;31:554–559.
44. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C,
Toutouza M, Stefanadis C. Acute systemic inﬂammation increases arterial
stiffness and decreases wave reﬂections in healthy individuals. Circulation.
2005;112:2193–2200.
45. Kumagai H, Zempo-Miyaki A, Yoshikawa T, Eto M, So R, Tsujimoto T, Nishiyasu
T, Tanaka K, Maeda S. Which cytokine is the most related to weight loss-
induced decrease in arterial stiffness in overweight and obese men? Endocr J.
2018;65:53–61.
DOI: 10.1161/JAHA.117.007964 Journal of the American Heart Association 11
Male Sexual Function and Arterial Stiffness Kumagai et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on July 26, 2018
